Shares of Proto Labs, Inc. (NYSE:PRLB – Get Free Report) have been given an average recommendation of “Buy” by the five research firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $53.3333.
A number of brokerages have recently commented on PRLB. Weiss Ratings reissued a “hold (c-)” rating on shares of Proto Labs in a report on Thursday, January 22nd. Benchmark increased their target price on Proto Labs from $45.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. Finally, Zacks Research upgraded Proto Labs from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 11th.
Check Out Our Latest Stock Report on PRLB
Insider Buying and Selling at Proto Labs
Institutional Investors Weigh In On Proto Labs
Hedge funds have recently made changes to their positions in the business. Group One Trading LLC bought a new position in shares of Proto Labs during the 4th quarter valued at $25,000. NewEdge Advisors LLC boosted its position in Proto Labs by 7,380.0% during the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock valued at $26,000 after buying an additional 738 shares during the period. NBC Securities Inc. bought a new position in shares of Proto Labs during the fourth quarter valued at about $46,000. Modus Advisors LLC bought a new stake in shares of Proto Labs in the 4th quarter valued at about $57,000. Finally, Aquatic Capital Management LLC purchased a new stake in Proto Labs during the 3rd quarter valued at about $64,000. 84.54% of the stock is currently owned by institutional investors.
Proto Labs Stock Up 1.5%
Proto Labs stock opened at $67.45 on Wednesday. Proto Labs has a 52 week low of $29.58 and a 52 week high of $68.91. The business has a 50-day simple moving average of $54.67 and a 200 day simple moving average of $51.49. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of 76.64 and a beta of 1.24.
Proto Labs (NYSE:PRLB – Get Free Report) last released its quarterly earnings results on Friday, February 6th. The industrial products company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.09. Proto Labs had a return on equity of 3.20% and a net margin of 3.98%.The firm had revenue of $136.49 million for the quarter, compared to analysts’ expectations of $129.07 million. During the same quarter last year, the firm posted $0.38 EPS. The company’s revenue was up 12.1% compared to the same quarter last year. Proto Labs has set its Q1 2026 guidance at 0.360-0.440 EPS. On average, research analysts anticipate that Proto Labs will post 0.81 earnings per share for the current year.
Proto Labs Company Profile
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
Read More
- Five stocks we like better than Proto Labs
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- URGENT: Sell this stock immediately
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
